These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 23938061)

  • 1. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J; Karrasch J; Haan J; Volc D
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D; Grunstein R; Sridhar G; Dreykluft T; Montagna P; Dom R; Lainey E; Moorat A; Roberts J
    Sleep Med; 2007 Nov; 8(7-8):742-52. PubMed ID: 17512789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.
    Trenkwalder C; Garcia-Borreguero D; Montagna P; Lainey E; de Weerd AW; Tidswell P; Saletu-Zyhlarz G; Telstad W; Ferini-Strambi L;
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):92-7. PubMed ID: 14707315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Bogan RK; Fry JM; Schmidt MH; Carson SW; Ritchie SY;
    Mayo Clin Proc; 2006 Jan; 81(1):17-27. PubMed ID: 16438474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome.
    Kushida CA; Geyer J; Tolson JM; Asgharian A
    Clin Neuropharmacol; 2008; 31(5):281-6. PubMed ID: 18836346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks.
    García-Borreguero D; Högl B; Ferini-Strambi L; Winkelman J; Hill-Zabala C; Asgharian A; Allen R
    Mov Disord; 2012 Feb; 27(2):277-83. PubMed ID: 22328464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
    J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
    Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
    Oertel W; Trenkwalder C; Beneš H; Ferini-Strambi L; Högl B; Poewe W; Stiasny-Kolster K; Fichtner A; Schollmayer E; Kohnen R; García-Borreguero D;
    Lancet Neurol; 2011 Aug; 10(8):710-20. PubMed ID: 21705273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
    Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
    Ma JF; Wan Q; Hu XY; Sun SG; Wang WZ; Zhao ZX; Wang YJ; Liu CF; Li JM; Jiang YP; Chen SD
    Sleep Med; 2012 Jan; 13(1):58-63. PubMed ID: 22137119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.
    Garcia-Borreguero D; Winkelman J; Adams A; Ellis A; Morris M; Lamb J; Layton G; Versavel M;
    Sleep Med; 2007 Mar; 8(2):119-27. PubMed ID: 17239657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
    Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.